Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells
The placebo group recorded only a 4.5% reduction in total fat mass, while retatrutide recipients saw fat mass fall by 15.2% in the 4mg group, 26.1% in the 8mg group and 23.2% in the 12mg group
The clinical trial is a double-blind, randomized, placebo-controlled study to assess the efficacy and safety of administering semaglutide 2.4 mg in 150 obese Asian patients weekly
Blandino-Rosano M, Scheys JO, Werneck-de-Castro JP, Louzada RA, Almaca J, Leibowitz G, Ruegg MA, Hall MN, Bernal-Mizrachi E
Conducted by Dr
They help rebuild skin structure , improving firmness and elasticity while reducing the appearance of fine lines and wrinkles